1
|
Ettinger DS, Akerley W, Borghaei H, Chang
AC, Cheney RT, Chirieac LR, DAmico TA, Demmy TL, Ganti AKP,
Govindan R, et al: NCCN (National Comprehensive Cancer Network):
Non-small cell lung cancer. J Natl Compr Canc Netw. 10:1236–1271.
2012.PubMed/NCBI
|
2
|
Goldstraw P, Ball D, Jett JR, Le Chevalier
T, Lim E, Nicholson AG and Shepherd FA: Non-small-cell lung cancer.
Lancet. 378:1727–1740. 2011. View Article : Google Scholar : PubMed/NCBI
|
3
|
Temel JS, Greer JA, Muzikansky A,
Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD,
Jacobsen J, Pirl WF, et al: Early palliative care for patients with
metastatic non-small-cell lung cancer. N Engl J Med. 363:733–742.
2010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Qi J and Mu D: MicroRNAs and lung cancers:
from pathogenesis to clinical implications. Front Med. 6:134–155.
2012. View Article : Google Scholar : PubMed/NCBI
|
5
|
Wang Y, Zhang X, Liu L, Li H, Yu J, Wang C
and Ren X: Clinical implication of microrna for lung cancer. Cancer
Biother Radiopharm. 28:261–267. 2013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Skrzypski M, Dziadziuszko R and Jassem J:
MicroRNA in lung cancer diagnostics and treatment. Mutat Res.
717:25–31. 2011. View Article : Google Scholar : PubMed/NCBI
|
7
|
Lin PY, Yu SL and Yang PC: MicroRNA in
lung cancer. Br J Cancer. 103:1144–1148. 2010. View Article : Google Scholar : PubMed/NCBI
|
8
|
Li Y, Zhang D, Chen C, Ruan Z, Li Y and
Huang Y: MicroRNA-212 displays tumor-promoting properties in
non-small cell lung cancer cells and targets the hedgehog pathway
receptor PTCH1. Mol Biol Cell. 23:1423–1434. 2012. View Article : Google Scholar : PubMed/NCBI
|
9
|
Liu X, Sempere LF, Ouyang H, Memoli VA,
Andrew AS, Luo Y, Demidenko E, Korc M, Shi W, Preis M, et al:
MicroRNA-31 functions as an oncogenic microRNA in mouse and human
lung cancer cells by repressing specific tumor suppressors. J Clin
Invest. 120:1298–1309. 2010. View
Article : Google Scholar : PubMed/NCBI
|
10
|
Liu XH, Lu KH, Wang KM, Sun M, Zhang EB,
Yang JS, Yin DD, Liu ZL, Zhou J, Liu ZJ, et al: MicroRNA-196a
promotes non-small cell lung cancer cell proliferation and invasion
through targeting HOXA5. BMC Cancer. 12:3482012. View Article : Google Scholar : PubMed/NCBI
|
11
|
Luo W, Huang B, Li Z, Li H, Sun L, Zhang
Q, Qiu X and Wang E: MicroRNA-449a is downregulated in non-small
cell lung cancer and inhibits migration and invasion by targeting
c-Met. PLoS One. 8:e647592013. View Article : Google Scholar : PubMed/NCBI
|
12
|
Mei Z, He Y, Feng J, Shi J, Du Y, Qian L,
Huang Q and Jie Z: MicroRNA-141 promotes the proliferation of
non-small cell lung cancer cells by regulating expression of PHLPP1
and PHLPP2. FEBS Lett. 588:3055–3061. 2014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Ohdaira H, Sekiguchi M, Miyata K and
Yoshida K: MicroRNA-494 suppresses cell proliferation and induces
senescence in A549 lung cancer cells. Cell Prolif. 45:32–38. 2012.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Bonauer A and Dimmeler S: The
microRNA-17-92 cluster: still a miRacle? Cell Cycle. 8:3866–3873.
2009. View Article : Google Scholar : PubMed/NCBI
|
15
|
Lin Q, Chen T, Lin Q, Lin G, Lin J, Chen G
and Guo L: Serum miR-19a expression correlates with worse prognosis
of patients with non-small cell lung cancer. J Surg Oncol.
107:767–771. 2013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Wu Q, Yang Z, An Y, Hu H, Yin J, Zhang P,
Nie Y, Wu K, Shi Y and Fan D: MiR-19a/b modulate the metastasis of
gastric cancer cells by targeting the tumour suppressor MXD1. Cell
Death Dis. 5:e11442014. View Article : Google Scholar : PubMed/NCBI
|
17
|
Ha TY: MicroRNAs in human diseases: From
cancer to cardiovascular disease. Immune Netw. 11:135–154. 2011.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Mu P, Han YC, Betel D, Yao E, Squatrito M,
Ogrodowski P, de Stanchina E, DAndrea A, Sander C and Ventura A:
Genetic dissection of the miR-17-92 cluster of microRNAs in
Myc-induced B-cell lymphomas. Genes Dev. 23:2806–2811. 2009.
View Article : Google Scholar : PubMed/NCBI
|
19
|
ODonnell KA, Wentzel EA, Zeller KI, Dang
CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1
expression. Nature. 435:839–843. 2005. View Article : Google Scholar : PubMed/NCBI
|
20
|
Ayer DE, Kretzner L and Eisenman RN: Mad:
a heterodimeric partner for Max that antagonizes Myc
transcriptional activity. Cell. 72:211–222. 1993. View Article : Google Scholar : PubMed/NCBI
|
21
|
Song DW, Ryu JY, Kim JO, Kwon EJ and Kim
H: The miR-19a/b family positively regulates cardiomyocyte
hypertrophy by targeting atrogin-1 and MuRF-1. Biochem J.
457:151–162. 2014. View Article : Google Scholar : PubMed/NCBI
|
22
|
Chen B, She S, Li D, Liu Z, Yang X, Zeng Z
and Liu F: Role of miR-19a targeting TNF-α in mediating ulcerative
colitis. Scand J Gastroenterol. 48:815–824. 2013. View Article : Google Scholar : PubMed/NCBI
|
23
|
Qin S, Ai F, Ji WF, Rao W, Zhang HC and
Yao WJ: miR-19a promotes cell growth and tumorigenesis through
targeting SOCS1 in gastric cancer. Asian Pac J Cancer Prev.
14:835–840. 2013. View Article : Google Scholar : PubMed/NCBI
|
24
|
Pezzolesi MG, Platzer P, Waite KA and Eng
C: Differential expression of PTEN-targeting microRNAs miR-19a and
miR-21 in cowden syndrome. Am J Hum Genet. 82:1141–1149. 2008.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Xu XM, Wang XB, Chen MM, Liu T, Li YX, Jia
WH, Liu M, Li X and Tang H: MicroRNA-19a and −19b regulate cervical
carcinoma cell proliferation and invasion by targeting CUL5. Cancer
Lett. 322:148–158. 2012. View Article : Google Scholar : PubMed/NCBI
|
26
|
Wu Q, Yang Z, An Y, Hu H, Yin J, Zhang P,
Nie Y, Wu K, Shi Y and Fan D: MiR-19a/b modulate the metastasis of
gastric cancer cells by targeting the tumour suppressor MXD1. Cell
Death Dis. 5:e11442014. View Article : Google Scholar : PubMed/NCBI
|
27
|
Ohta Y, Hamada Y, Saitoh N and Katsuoka K:
Effect of the transcriptional repressor Mad1 on proliferation of
human melanoma cells. Exp Dermatol. 11:439–447. 2002. View Article : Google Scholar : PubMed/NCBI
|